The appearance of hepatoma-associated chromosomal non-histone proteins in rat liver after a single dose of 3'-MDAB followed by treatment of phenobarbital.
Previously we have described polyclonal antibodies that recognized a group of nuclear nonhistone proteins whose molecular weights ranged in size from 170 to 220 kDa. These antigenic nonhistone chromosomal proteins are abundant in rat hepatoma chromatin. In this report we discuss the synthesis and cellular localization of these particular proteins during the multistage process of hepatocarcinogenesis. The appearance of these antigenic proteins in rat liver nuclei approximately parallels the appearance of alpha-fetoprotein in the cytosol of hepatocytes. However, the immunoreactivity of antigenic proteins increased steadily even during the prominent dip in the AFP concentration between 50 and 100 days of carcinogenesis. The effect of the tumor promoting agent, phenobarbital, on the synthesis of antigenic nuclear proteins was also studied. The appearance of hepatoma-associated non-histone chromosomal proteins at early stages of tumor promotion during hepatocarcinogenesis was observed. The results of these studies demonstrate that the hepatoma-associated non-histone proteins are expressed not only in hepatoma cells, but also in hepatocyte cells committed to carcinogenesis.
Department of Biochemistry, University of Vermont College of Medicine, Burlington 05405.
J M
JM
Dong
Z
Z
Kilianska
K
K
Fukuda
J F
JF
Chiu
D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis*; D002467:Cell Nucleus / Q000187:drug effects; D002843:Chromatin / Q000032:analysis; D002868:Chromosomal Proteins, Non-Histone / Q000032:analysis*; D003043:Cocarcinogenesis; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D006498:Hepatectomy; D015151:Immunoblotting; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000378:metabolism*; D008297:Male; D008749:Methyldimethylaminoazobenzene / Q000008:administration & dosage / Q000633:toxicity*; D010634:Phenobarbital / Q000494:pharmacology*; D011230:Precancerous Conditions / Q000139:chemically induced / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D000509:alpha-Fetoproteins / Q000032:analysis; D004124:p-Dimethylaminoazobenzene
D014408:Biomarkers, Tumor; D002843:Chromatin; D002868:Chromosomal Proteins, Non-Histone; D000509:alpha-Fetoproteins; D008749:Methyldimethylaminoazobenzene; D004124:p-Dimethylaminoazobenzene; D010634:Phenobarbital